title: Pulsed levosimendan therapy in the management of chronic end stage cardiac failure in 'adult congenital heart disease'.
authors.affiliation: Norfolk and Norwich University Hospital, United Kingdom.
authors.forename: I
authors.initials: I
authors.lastname: Rafiq
authors.affiliation: Norfolk and Norwich University Hospital, United Kingdom. Electronic address: leisa.freeman@nnuh.nhs.uk.
authors.forename: Leisa J
authors.initials: LJ
authors.lastname: Freeman
mesh_terms: D000328:Adult; D006348:Cardiac Surgical Procedures / Q000009:adverse effects* / Q000379:methods; D002316:Cardiotonic Agents / Q000008:administration & dosage; D018450:Disease Progression; D005260:Female; D006330:Heart Defects, Congenital / Q000150:complications / Q000601:surgery; D006333:Heart Failure / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology / Q000523:psychology; D006801:Humans; D006835:Hydrazones / Q000008:administration & dosage*; D008017:Life Expectancy; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000175:diagnosis / Q000188:drug therapy / Q000503:physiopathology / Q000523:psychology; D011724:Pyridazines / Q000008:administration & dosage*; D011788:Quality of Life; D012720:Severity of Illness Index; D000077464:Simendan; D016896:Treatment Outcome
chemical_list: D002316:Cardiotonic Agents; D006835:Hydrazones; D011724:Pyridazines; D000077464:Simendan
keywords: Adult congenital heart disease; Cardiac failure; Therapeutics levosimendan